• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

cancer - Articles and news items

predosing-red-bone-marrow

Predosing NHL patients with lilotomab before betalutin therapy lowers haematological toxicity

Industry news / 5 September 2016 / Niamh Louise Marriott, Digital Content Producer

RM radiation doses were significantly higher in the patients who did not receive predosing, indicating that pre-dosing with lilotomab has a protective…

New England Biolabs (UK) Ltd

New England Biolabs® launches NEBNext Direct™ Technology with Cancer HotSpot Panel

Supplier news / 8 August 2016 / New England Biolabs, Inc.

Novel target enrichment technology, compatible with low input amounts from challenging sample types, uses a one-day workflow…

GSK UoL collaborate cancer treatment

GSK teams up with University of Leicester in search of cancer treatments

Industry news / 21 July 2016 / Niamh Louise Marriott, Digital Content Producer

global pharmaceutical company GlaxoSmithKline has been established to discover and develop novel medicines to treat aggressive forms of blood cancer…

Cancer immunotherapy candidate

Cancer treatment receives EU drug designations

Industry news / 20 July 2016 / Niamh Louise Marriott, Digital Content Producer

With the EU orhpan drug designations, Cell Medica can now obtain regulatory and financial incentives for developing and marketing CMD-003 as a cancer…

Gazyvaro Roche

Blood cancer study yields disappointing results

Industry news / 19 July 2016 / Niamh Louise Marriott

Gazyvaro did not meet its primary endpoint of significantly reducing the risk of disease worsening or death in people with diffuse large B-cell lymphoma…

blood-clots

New clinical research programme launched for the prevention and treatment of blood clots in patients with cancer

Industry news / 29 May 2015 / VIctoria White

Janssen and Bayer have launched a clinical research programme evaluating rivaroxaban for the prevention and treatment of blood clots in patients with cancer…

Sanofi Aventis logo

Sanofi-aventis withdraws its marketing authorisation application for Mulsevo

Industry news, News / 9 July 2012 / European Medicines Agency (EMA)

The EMA has been notified by Sanofi-aventis of its decision to withdraw its marketing authorisation application for Mulsevo…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +